BPC-157
Synthetic Pentadecapeptide (research chemical)
The human evidence base is essentially empty — no randomized or clinical trials — so no efficacy claim can be graded, and human safety is unknown. Interest and animal data are real; human proof is not.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
Limited evidence
The human evidence base is essentially empty — no randomized or clinical trials — so no efficacy claim can be graded, and human safety is unknown. Interest and animal data are real; human proof is not.
Early or sparse human evidence; conclusions remain uncertain.
Human Evidence
No human RCTs or clinical efficacy trials indexed; case reports and marketing only.
Mechanistic Plausibility
Animal studies suggest angiogenic and tissue-repair pathways — plausibility, not proof.
Research Activity
An active but narrow preclinical literature, much from a single research group.
Safety Profile
No human safety data; unregulated products of unknown purity/identity/dose.
Consensus
No guideline or regulatory endorsement; not approved.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
3/9
steps proven in humans
Evidence-poor
6 steps not demonstrated: Human biomarker / pharmacology · Human safety data · Small human outcome trials · Large human RCTs · Clinical outcomes · Guideline / regulatory support
Guideline / regulatory support
Not shownNot approved.
Clinical outcomes
Not shownNone.
Large human RCTs
Not shownNone.
Small human outcome trials
Not shownNone.
Human safety data
Not shownNo controlled human safety data.
Human biomarker / pharmacology
Not shownNo human pharmacology data.
Animal
ProvenThe entire efficacy literature is animal.
Cell / in vitro
ProvenPreclinical cell studies.
Mechanistic plausibility
ProvenAngiogenic / tissue-repair pathways proposed.
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
Animal data only
There is a substantial animal/preclinical literature suggesting BPC-157 may accelerate healing of muscle, tendon, ligament, gut, and other tissues. There are no human efficacy trials.
Plausible, not proven
The mechanism is plausible enough to justify human research, but plausibility is not evidence of human benefit — many peptides with strong animal data fail in humans.
Everything human
Whether it works in humans at all, safe dose, long-term safety, and product identity/purity in the unregulated market are unknown.
Preclinical + regulatory review
Continued preclinical work; regulatory review of its compounding status.
What would change the picture
A single well-conducted human randomized trial would, for the first time, allow any graded efficacy claim.
The biggest myth
“BPC-157 is a proven recovery peptide.”
'Proven' is unsupported — the human evidence base is empty.
Ask BioSignal
Still have a question about bpc-157?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take bpc-157
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
People search BPC-157 for tendon, ligament, and muscle injury healing, gut healing, and general recovery. Interest vastly exceeds evidence: the healing story rests on animal studies only, with no human trials and unknown human safety.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Not Approved
Availability
Unapproved research chemical
Sport (WADA)
Assume prohibited (non-approved substance, S0) — requires confirmation
Known safety profile
Unknown in humans — no controlled human safety data.
Common issues
- Not characterized; anecdotal reports are unreliable
Use caution if
- Everyone (human safety unestablished; unregulated product)
- Pregnancy
- Cancer history (theoretical angiogenic concern)
Long-term unknowns
All long-term human safety.
Limits of this evidence
The entire efficacy literature is preclinical; human safety is a genuine unknown, not a reassurance.
Full regulatory and sport detail
- Regulatory approval
- None.
- Approved indication
- None.
- Investigational
- No active efficacy IND.
- Research chemical
- Yes — sold as a 'research chemical' outside pharmaceutical quality control.
- Compounding
- Not permitted under 503A due to identified safety concerns; status under active FDA review as of mid-2026 — requires confirmation.
- Sport (WADA)
- As a non-approved substance, athletes should assume it is prohibited (S0) — requires confirmation.
- Publication note
- Re-confirm regulatory and anti-doping status against primary FDA/WADA sources at publication.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 4 popular claims about bpc-157.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Insufficient evidence
- 1
- Not established
- 3
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Insufficient evidence
- BPC-157 heals tendon/muscle/joint injuries in people.
Not established
- BPC-157 is a proven recovery peptide.
- BPC-157 is safe.
- BPC-157 is legal / approved.
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
BPC-157 heals tendon/muscle/joint injuries in people.Insufficient evidenceLimited evidence
Evidence is animal-only; there are no human efficacy trials to support (or refute) the claim.
BPC-157 is safe.Not establishedCaution
There is no human safety data; products are unregulated and of unknown composition.
BPC-157 is legal / approved.Not establishedModerate confidence
Not FDA-approved; not eligible for compounding due to safety concerns; sold as a research chemical. Athletes should assume it is prohibited in sport.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
—
- Intervention
- —
- Dose
- None
- Duration
- —
- Outcome
- —
- Notes
- No controlled human studies exist. Market doses are not evidence-based and are reported as absent, not endorsed.
Where scientists agree — and don’t
Agreed
- The preclinical/animal literature is real and suggests tissue-repair activity
Debated
- Whether animal effects will translate to humans
- The reliability of a literature concentrated in few groups
- The meaning of anecdotal human reports
Unknown
- Essentially all human questions — efficacy, dose, safety, and product quality
What remains unknown
- Is there any human efficacy, for any indication?
- What is a safe human dose and the short/long-term safety?
- What is the product identity/purity in unregulated supply?
Questions people actually ask
Does BPC-157 heal injuries?
In animals, studies suggest it may speed tissue healing — but there are no human trials, so whether it works (or is safe) in people is unknown. Its reputation runs far ahead of its evidence.
Is BPC-157 legal?
It is not FDA-approved and is not permitted for pharmacy compounding due to safety concerns; it is sold as an unregulated research chemical, and athletes should assume it is prohibited in sport.
Practical takeaways
- BPC-157 is marketed far beyond its evidence: animal data only, no human trials.
- Human efficacy and safety are unknown — BioSignal cannot recommend it.
- It is not FDA-approved and is sold as an unregulated research chemical of unknown quality.
- Athletes should assume it is prohibited in sport (non-approved substance).
- For injury recovery, the evidence-based levers are sleep, protein, progressive loading, and time — not an unproven peptide.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
How we found out
1990s–2020s — Preclinical era
Extensive animal/in-vitro studies of tissue healing.
Ongoing — no human efficacy trials
Regulatory review of compounding status.
References
Verified sources. BioSignal does not print a citation it has not checked.
- 01
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Cell Tissue Res 377(2):153-159 · 2019
- 02
BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing
Curr Pharm Des 24(18):1972-1989 · 2018
- 03
Fistulas healing. Stable gastric pentadecapeptide BPC 157 therapy
Curr Pharm Des 26(25):2991-3000 · 2020
Version history
1.0
Initial review-hardened record (Experimental; Insufficient/Caution). Review cadence: Semiannual (science static; regulatory status changing).
Continue exploring
Three places this record leads next.